Zu Inhalt springen

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Conditions: Plaque Psoriasis
Interventions: Drug: Deucravacitinib; Other: Placebo
Sponsors: Bristol-Myers Squibb
Not yet recruiting

Den kompletten Artikel zeigen

Nutzer-Rückmeldung

Es gibt noch keine Rezensionen.